How COVID-19 pandemic changed our attitude to venetoclax-based treatment in chronic lymphocytic leukemia

Marina Deodato; Anna Maria Frustaci; Paolo Sportoletti; Luca Laurenti; Roberta Murru; Andrea Visentin; Gianluigi Reda; Francesca Romana Mauro; Giulia Quaresmini; Anna Vanazzi; Candida Vitale; Lorella Orsucci; Massimo Massaia; Alessandro Sanna; Marina Motta; Adalberto Ibatici; Isacco Ferrarini; Chiara Borella; Marzia Varettoni; Monica Tani; Sara Marinoni; Andrea Ferrario; Giulia Zamprogna; Marco Montillo; Alessandra Tedeschi

doi:10.1080/10428194.2022.2053532

How COVID-19 pandemic changed our attitude to venetoclax-based treatment in chronic lymphocytic leukemia

Marina Deodato, Anna Maria Frustaci, Paolo Sportoletti, Luca Laurenti, Roberta Murru, Andrea Visentin, Gianluigi Reda, Francesca Romana Mauro, Giulia Quaresmini, Anna Vanazzi, Candida Vitale, Lorella Orsucci, Massimo Massaia, Alessandro Sanna, Marina Motta, Adalberto Ibatici, Isacco Ferrarini, Chiara Borella, Marzia Varettoni, Monica TaniSara Marinoni, Andrea Ferrario, Giulia Zamprogna, Marco Montillo, Alessandra Tedeschi

Risultato della ricerca: Contributo in rivista › Articolo in rivista

Abstract

NA

Lingua originale	English
pagine (da-a)	1985-1988
Numero di pagine	4
Rivista	LEUKEMIA & LYMPHOMA
Volume	63
DOI	https://doi.org/10.1080/10428194.2022.2053532
Stato di pubblicazione	Pubblicato - 2022

Keywords

COVID-19
Chronic lymphocytic leukemia
Rituximab
venetoclax

Accesso al documento

10.1080/10428194.2022.2053532

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

Deodato, M., Frustaci, A. M., Sportoletti, P., Laurenti, L., Murru, R., Visentin, A., Reda, G., Mauro, F. R., Quaresmini, G., Vanazzi, A., Vitale, C., Orsucci, L., Massaia, M., Sanna, A., Motta, M., Ibatici, A., Ferrarini, I., Borella, C., Varettoni, M., ... Tedeschi, A. (2022). How COVID-19 pandemic changed our attitude to venetoclax-based treatment in chronic lymphocytic leukemia. LEUKEMIA & LYMPHOMA, 63, 1985-1988. https://doi.org/10.1080/10428194.2022.2053532

@article{c084ae26157d4fd998ab95e5541d743f,

title = "How COVID-19 pandemic changed our attitude to venetoclax-based treatment in chronic lymphocytic leukemia",

abstract = "NA",

keywords = "COVID-19, Chronic lymphocytic leukemia, Rituximab, venetoclax, COVID-19, Chronic lymphocytic leukemia, Rituximab, venetoclax",

author = "Marina Deodato and Frustaci, {Anna Maria} and Paolo Sportoletti and Luca Laurenti and Roberta Murru and Andrea Visentin and Gianluigi Reda and Mauro, {Francesca Romana} and Giulia Quaresmini and Anna Vanazzi and Candida Vitale and Lorella Orsucci and Massimo Massaia and Alessandro Sanna and Marina Motta and Adalberto Ibatici and Isacco Ferrarini and Chiara Borella and Marzia Varettoni and Monica Tani and Sara Marinoni and Andrea Ferrario and Giulia Zamprogna and Marco Montillo and Alessandra Tedeschi",

year = "2022",

doi = "10.1080/10428194.2022.2053532",

language = "English",

volume = "63",

pages = "1985--1988",

journal = "LEUKEMIA & LYMPHOMA",

issn = "1042-8194",

publisher = "Taylor & Francis Limited:Rankine Road, Basingstoke RG24 8PR United Kingdom:011 44 1256 813035, EMAIL: [email protected], [email protected], INTERNET: http://www.tandf.co.uk, Fax: 011 44 1256 330245",

}

Deodato, M, Frustaci, AM, Sportoletti, P, Laurenti, L, Murru, R, Visentin, A, Reda, G, Mauro, FR, Quaresmini, G, Vanazzi, A, Vitale, C, Orsucci, L, Massaia, M, Sanna, A, Motta, M, Ibatici, A, Ferrarini, I, Borella, C, Varettoni, M, Tani, M, Marinoni, S, Ferrario, A, Zamprogna, G, Montillo, M & Tedeschi, A 2022, 'How COVID-19 pandemic changed our attitude to venetoclax-based treatment in chronic lymphocytic leukemia', LEUKEMIA & LYMPHOMA, vol. 63, pagg. 1985-1988. https://doi.org/10.1080/10428194.2022.2053532

TY - JOUR

T1 - How COVID-19 pandemic changed our attitude to venetoclax-based treatment in chronic lymphocytic leukemia

AU - Deodato, Marina

AU - Frustaci, Anna Maria

AU - Sportoletti, Paolo

AU - Laurenti, Luca

AU - Murru, Roberta

AU - Visentin, Andrea

AU - Reda, Gianluigi

AU - Mauro, Francesca Romana

AU - Quaresmini, Giulia

AU - Vanazzi, Anna

AU - Vitale, Candida

AU - Orsucci, Lorella

AU - Massaia, Massimo

AU - Sanna, Alessandro

AU - Motta, Marina

AU - Ibatici, Adalberto

AU - Ferrarini, Isacco

AU - Borella, Chiara

AU - Varettoni, Marzia

AU - Tani, Monica

AU - Marinoni, Sara

AU - Ferrario, Andrea

AU - Zamprogna, Giulia

AU - Montillo, Marco

AU - Tedeschi, Alessandra

PY - 2022

Y1 - 2022

N2 - NA

AB - NA

KW - COVID-19

KW - Chronic lymphocytic leukemia

KW - Rituximab

KW - venetoclax

KW - COVID-19

KW - Chronic lymphocytic leukemia

KW - Rituximab

KW - venetoclax

UR - http://hdl.handle.net/10807/235513

U2 - 10.1080/10428194.2022.2053532

DO - 10.1080/10428194.2022.2053532

M3 - Article

SN - 1042-8194

VL - 63

SP - 1985

EP - 1988

JO - LEUKEMIA & LYMPHOMA

JF - LEUKEMIA & LYMPHOMA

ER -

How COVID-19 pandemic changed our attitude to venetoclax-based treatment in chronic lymphocytic leukemia

Abstract

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo